The drug Myrbetriq which has been approved by FDA for use in OAB patients will be available in all worldwide pharmacies in the last quarter of the year is found to enhance the storage of bladder along with alleviating the patients' need of frequent urination, which is normally involuntary.
The Astellas Pharma US, Inc's extended release tablets of Myrbetriq has been approved by the FDA (Food and Drug Administration) for curing symptoms ...
Satisfied Users & 
Approved Press Releases
